Evidence map›Paper›PMID 40924295›Full record

ArticleJournal of epidemiology and global health2025

National Update on Healthcare-Associated Infections in Iran for 2023-Based on the Iranian Nosocomial Infections Surveillance (INIS) System.

Arash Seifi, Mohammad Zeinali, Kianoush Kamali, Shirin Afhami, Marjan Rahnamaye-Farzami, Ronak Miladi, Maryam Shafaati

Abstract read
In one paragraph

Article in Journal of epidemiology and global health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Burden and Economic Impact of Antimicrobial Resistance inThe Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Arash SeifiCenter for Communicable Diseases Control (CDC), Ministry of Health and Medical Education, Tehran, Iran.
Mohammad ZeinaliCenter for Communicable Diseases Control (CDC), Ministry of Health and Medical Education, Tehran, Iran.
Kianoush KamaliCenter for Communicable Diseases Control (CDC), Ministry of Health and Medical Education, Tehran, Iran.
Shirin AfhamiDepartment of Infectious Diseases, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
Marjan Rahnamaye-FarzamiDepartment of Microbiology, Research Center of Health Reference Laboratories, Ministry of Health and Medical Education, Tehran, Iran.
Ronak MiladiDepartment of Infectious Disease, School of Medicine, Kermanshah University of Medical Sciences, Kermanshah, Iran. miladironak009752@yahoo.com.
Maryam ShafaatiCenter for Communicable Diseases Control (CDC), Ministry of Health and Medical Education, Tehran, Iran. Maryam.shafaati@gmail.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundHealthcare-associated infections (HCAIs) pose a serious threat to healthcare systems. Accurately determining the incidence of HCAIs is crucial for planning and implementing efficient interventions, as they are associated with a wide range of challenges. The objective of this study was to assess and update the incidence rates of HCAIs in Iran in 2023, using data from the Iranian Nosocomial Infection Surveillance (INIS) system, a nationwide hospital-based surveillance program.

methodsThe Iranian Center for Communicable Diseases Control (ICDC) evaluated data from 1,066 hospitals using the INIS software. Hospitals' trained infection control staff collected all information and entered it into the INIS. HCAIs were diagnosed based on the CDC/NHSN case definition criteria. We calculated incidence rate (per 100 admissions and per 1,000 patient-days).

resultsWe reported 170,948 HCAIs among 11,043,373 hospitalized patients, with an incidence rate of 4.95 per 1,000 patient-days, and the crude mortality rate of 19.85%. Looking at the relative frequencies, Pneumonia was the most frequent infection (28.32%), followed by urinary tract infections (UTIs) (26.6%), and surgical site infections (SSIs) (21.85%). HCAI rates were highest in intensive care units (ICUs), transplant wards, and burn units, with major surgeries like cardiovascular, neurosurgeries, and orthopedics having the highest SSI rates. The most common microorganisms were Klebsiella spp. (16.56%) and E. coli (14.6%), with high proportions of multidrug-resistance (MDR) including MRSA (43.2%), VRE (65.24%), and KPC (74.21%).

conclusionsThis study reveals a high incidence of HCAIs in Iranian hospitals in 2023, with pneumonia, UTIs, and SSIs being most common. The high proportion of MDR pathogens underscores the need for enhanced infection control, antibiotic stewardship program, and continuous staff education to reduce HCAIs and improve patient outcomes.

Indexed as

Cross InfectionPopulation SurveillanceAdolescentAdultAgedChildChild, PreschoolFemaleHumansIncidenceInfantIranMaleMiddle AgedYoung AdultAntimicrobial resistanceHealthcare-associated infectionsIncidenceIranSurveillance

Identifiers

PMID40924295
PMCPMC12420528

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.